These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


283 related items for PubMed ID: 30536846

  • 1. Clinical utility of plasma miR-371a-3p in germ cell tumors.
    Mego M, van Agthoven T, Gronesova P, Chovanec M, Miskovska V, Mardiak J, Looijenga LHJ.
    J Cell Mol Med; 2019 Feb; 23(2):1128-1136. PubMed ID: 30536846
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Serum miRNA Predicts Viable Disease after Chemotherapy in Patients with Testicular Nonseminoma Germ Cell Tumor.
    Leão R, van Agthoven T, Figueiredo A, Jewett MAS, Fadaak K, Sweet J, Ahmad AE, Anson-Cartwright L, Chung P, Hansen A, Warde P, Castelo-Branco P, O'Malley M, Bedard PL, Looijenga LHJ, Hamilton RJ.
    J Urol; 2018 Jul; 200(1):126-135. PubMed ID: 29474847
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Evaluation of miR-371a-3p to predict viable germ cell tumor in patients with pure seminoma receiving retroperitoneal lymph node dissection.
    Konneh B, Lafin JT, Howard J, Gerald T, Amini A, Savelyeva A, Woldu SL, Lewis CM, Jia L, Margulis V, Coleman N, Scarpini C, Frazier AL, Murray MJ, Amatruda JF, Bagrodia A.
    Andrology; 2023 May; 11(4):634-640. PubMed ID: 36254623
    [Abstract] [Full Text] [Related]

  • 11. MicroRNA miR-371a-3p - A Novel Serum Biomarker of Testicular Germ Cell Tumors: Evidence for Specificity from Measurements in Testicular Vein Blood and in Neoplastic Hydrocele Fluid.
    Dieckmann KP, Spiekermann M, Balks T, Ikogho R, Anheuser P, Wosniok W, Loening T, Bullerdiek J, Belge G.
    Urol Int; 2016 May; 97(1):76-83. PubMed ID: 26989896
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Circulating serum miRNA (miR-367-3p, miR-371a-3p, miR-372-3p and miR-373-3p) as biomarkers in patients with testicular germ cell cancer.
    Syring I, Bartels J, Holdenrieder S, Kristiansen G, Müller SC, Ellinger J.
    J Urol; 2015 Jan; 193(1):331-7. PubMed ID: 25046619
    [Abstract] [Full Text] [Related]

  • 14. MiR-371a-3p Serum Levels Are Increased in Recurrence of Testicular Germ Cell Tumor Patients.
    Terbuch A, Adiprasito JB, Stiegelbauer V, Seles M, Klec C, Pichler GP, Resel M, Posch F, Lembeck AL, Stöger H, Szkandera J, Pummer K, Bauernhofer T, Hutterer GC, Gerger A, Stotz M, Pichler M.
    Int J Mol Sci; 2018 Oct 12; 19(10):. PubMed ID: 30321995
    [Abstract] [Full Text] [Related]

  • 15. Micro-RNA-371a-3p in Germ Cell Testicular Tumors on Diagnosis: A Prospective Case-Control Study in Turkish Population.
    Kılınç MT, Göger YE, Özkent MS, Kılıç Ö, Okur Altındaş B, Yıldırım MS, Karalezli G.
    Urol J; 2024 Jun 09; 21(4):242-249. PubMed ID: 38629199
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. High Expression of microRNA-371a-3p in Cystic Fluid of Post-Chemotherapy Teratoma with Concurrent Normal Serum Levels in Patients with Non-Seminomatous Testicular Germ Cell Tumours.
    Dieckmann KP, Hennig F, Anheuser P, Gehrckens R, Viehweger F, Wülfing C, Belge G.
    Urol Int; 2021 Jun 09; 105(1-2):21-26. PubMed ID: 33049748
    [Abstract] [Full Text] [Related]

  • 18. The Novel Biomarker of Germ Cell Tumours, Micro-RNA-371a-3p, Has a Very Rapid Decay in Patients with Clinical Stage 1.
    Radtke A, Hennig F, Ikogho R, Hammel J, Anheuser P, Wülfing C, Belge G, Dieckmann KP.
    Urol Int; 2018 Jun 09; 100(4):470-475. PubMed ID: 29698973
    [Abstract] [Full Text] [Related]

  • 19. MicroRNAs miR-371-3 in serum as diagnostic tools in the management of testicular germ cell tumours.
    Dieckmann KP, Spiekermann M, Balks T, Flor I, Löning T, Bullerdiek J, Belge G.
    Br J Cancer; 2012 Nov 06; 107(10):1754-60. PubMed ID: 23059743
    [Abstract] [Full Text] [Related]

  • 20. Serum Levels of MicroRNA371a-3p: A Highly Sensitive Tool for Diagnosing and Staging Testicular Germ Cell Tumours: A Clinical Case Series.
    Anheuser P, Radtke A, Wülfing C, Kranz J, Belge G, Dieckmann KP.
    Urol Int; 2017 Nov 06; 99(1):98-103. PubMed ID: 28586780
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 15.